CLC Bio Partners with South Africa's Inqaba on TB Sequencing Study | GenomeWeb
NEW YORK (GenomeWeb News) - CLC Bio is partnering with Inqaba Biotechnical Industries, a genomic services firm based in Pretoria, South Africa, to sequence, assemble, and analyze data from multiple strains of Mycobacterium tuberculosis, the bioinformatics firm said last week.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.